Skip to content

OUTCOMES OF MECONIUM ASPIRATION SYNDROME IN BABIES WHO ARE BORN AT OR AFTER 37 WEEKS OF PREGNANCY

OUTCOMES OF MECONIUM ASPIRATION SYNDROME IN BABIES WITH GESTATIONAL AGE EQUAL TO OR MORE THAN 37 WEEKS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/06/034363
Enrollment
130
Registered
2021-06-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P240- Meconium aspiration

Interventions

Intervention1: No intervention: Observational study of meconium aspiration syndrome

Sponsors

ANJITH KRISHNAN R
Lead Sponsor
Swami Dayanand hospital
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Participants: Inclusion Criteria: •Inborn babies with gestational age equal to or more than 37 weeks Diagnosis of MAS will be based on the following criteria •Delivery through MSAF •Development of respiratory distress within 4 hours after birth and persistence beyond 24 hours. •Chest X-ray showing features of infiltrations, hyperinflation and atelectasis. •Absence of any other cause to explain the respiratory distress. •Parents signing the informed consent.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: • Babies with major congenital anomalies •Babies with Meconium stained amniotic fluid without respiratory distress •New borns with Transient tachypnea of newborn (TTN), Hyaline membrane disease (HMD) , sepsis as initial diagnosis

Design outcomes

Primary

MeasureTime frame
Outcome measures: Primary Outcomes â?¢Mortality rate in neonates with gestational age equal to or more than 37 weeks with meconium aspiration syndrome Timepoint: 4-8 weeks

Secondary

MeasureTime frame
Secondary Outcomes â?¢Percentage of babies requiring invasive ventilation in the study group â?¢Percentage of babies requiring non invasive ventilation in the study group â?¢Average duration of stay in NICU in the study group Timepoint: 4-8weeks

Countries

India

Contacts

Public ContactDr Anand Agarwal

Swami Dayanand hospital

anand1hari@gmail.com9810902271

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026